Q4 2023 · 13F-HR
5AM Venture Management, LLCholdings as filed
Filed 2024-02-14 · accession 0001104659-24-023676
$377.0M
Reported value
25
Positions
2023-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 29337E102 | ELVN | ENLIVEN THERAPEUTICS INC | $71.4M | 18.9% | 5,160,975 | Common | SOLE |
| 29384C108 | TRDA | ENTRADA THERAPEUTICS INC | $66.5M | 17.6% | 4,408,379 | Common | SOLE |
| N69605108 | PHVS | PHARVARIS N V | $22.4M | 5.93% | 797,600 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $19.7M | 5.23% | 497,270 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $18.3M | 4.85% | 302,630 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $17.1M | 4.54% | 399,972 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $17.0M | 4.51% | 294,221 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $15.3M | 4.06% | 1,472,264 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $14.3M | 3.80% | 521,531 | Common | SOLE |
| 929033108 | — | VOR BIOPHARMA INC | $14.3M | 3.80% | 6,361,723 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $12.8M | 3.39% | 586,595 | Common | SOLE |
| 60468T105 | MRTXEUR | MIRATI THERAPEUTICS INC | $11.3M | 3.00% | 192,500 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $10.9M | 2.89% | 585,000 | Common | SOLE |
| 75120L100 | — | RALLYBIO CORP | $8.7M | 2.30% | 3,630,724 | Common | SOLE |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $7.7M | 2.04% | 554,979 | Common | SOLE |
| 032724106 | ANAB | ANAPTYSBIO INC | $7.7M | 2.03% | 357,733 | Common | SOLE |
| 810648105 | SCPH | SCPHARMACEUTICALS INC | $7.5M | 2.00% | 1,200,647 | Common | SOLE |
| 98943L107 | ZNTL | ZENTALIS PHARMACEUTICALS INC | $7.4M | 1.97% | 490,000 | Common | SOLE |
| 85209E109 | — | SPRUCE BIOSCIENCES INC | $6.9M | 1.84% | 2,364,000 | Common | SOLE |
| 05370A108 | RNAGBP | AVIDITY BIOSCIENCES INC | $6.0M | 1.60% | 665,555 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $4.6M | 1.23% | 790,440 | Common | SOLE |
| 59045L106 | — | MERSANA THERAPEUTICS INC | $3.0M | 0.80% | 1,305,000 | Common | SOLE |
| 438083107 | FIXXEUR | HOMOLOGY MEDICINES INC | $2.8M | 0.73% | 4,535,919 | Common | SOLE |
| G3855L106 | GHRS | GH RESEARCH PLC | $2.3M | 0.62% | 404,404 | Common | SOLE |
| 171757107 | — | CIDARA THERAPEUTICS INC | $900,802 | 0.24% | 1,134,511 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.